Publication Name	World Journal of Clinical Oncology
Manuscript ID	7285
Country	Portugal

Received	2013-11-12 15:18
Peer-Review Started	2013-11-13 14:03
To Make the First Decision	2014-01-15 16:31
Return for Revision	2014-01-20 17:09
Revised	2014-02-18 02:41
Second Decision	2014-03-04 09:52
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2014-03-04 10:17
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor	2014-03-12 00:29
Typeset the Manuscript	2014-05-07 14:42
Publish the Manuscript Online	2014-05-12 18:06

ISSN	2218-4333 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Autobiography
Article Title	Evolution of costs of cancer drugs in a Portuguese hospital
Manuscript Source	Invited Manuscript
All Author List	Vânia Peixoto, Ana Luísa Faria, Márcia Gonçalves, Joana Macedo, Sónia Rego, Emilio Macías, Aldiro Magano, Márcia Loureiro and António Araújo
Funding Agency and Grant Number
Corresponding Author	António Araújo, MD, PhD, Department of Medical Oncology, Centro Hospitalar de Entre Douro e Vouga, Rua Doutor Cândido Pinho, 4520-211 Santa Maria da Feira, Portugal. amfaraujo@netcabo.pt
Key Words	Cancer; Costs; Drugs; Economy; Treatment
Core Tip	In the last decade costs related to cancer drugs have increased significantly. This growth seems to be explained by the increase in cancer incidence, new indications for treatment with previously approved cancer drugs and to placement of new drugs on the market, which are frequently more expensive than those already on sale. The results of the Karolinska Institute study demonstrated a substantial increase in available cancer drugs and costs between 1998 and 2007. The cost increment was not only related to the introduction of new drugs, but 68% of the costs in 2007 were due to drugs approved before 1999.
Publish Date	2014-05-12 18:06
Citation	Peixoto V, Faria AL, Gonçalves M, Macedo J, Rego S, Macías E, Magano A, Loureiro M, Araújo A. Evolution of costs of cancer drugs in a Portuguese hospital. World J Clin Oncol 2014; 5(2): 164-169
URL	http://www.wjgnet.com/2218-4333/full/v5/i2/164.htm
DOI	http://dx.doi.org/10.5306/wjco.v5.i2.164

Full Article (PDF)	WJCO-5-164.pdf
Full Article (Word)	WJCO-5-164.doc
Manuscript File	7285-Review.docx
Answering Reviewers	7285-Answering reviewers.pdf
Copyright License Agreement	7285-Copyright assignment.pdf
Peer-review Report	7285-Peer review(s).pdf
Scientific Editor Work List	7285-Scientific editor work list.doc